US OptionsDetailed Quotes
RIGL250117C30000
- 1.40
- 0.000.00%
15min DelayTrading Dec 4 13:20 ET
0.00High0.00Low
0.00Open1.40Pre Close0 Volume4 Open Interest30.00Strike Price0.00Turnover246.51%IV90.07%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry1.40Extrinsic Value100Contract SizeAmericanOptions Type0.2814Delta0.0313Gamma11.80Leverage Ratio-0.0729Theta0.0023Rho3.32Eff Leverage0.0148Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet